MAP3K2 and colonic neoplasm: Further analysis of the expression of 22 colon cancer samples showed significant (>2-fold increased) up-regulation of MAP3K2 in 77.3% (17/22) of patients, while there was an increase (>2-fold decrease) in 27.3% (6/22) of adjacent tissue samples (Figure 4H).